Sison, Marianne D., author

Hubbard, Jason C., author

Australia. Parliament. Senate. Economics Legislation Committee, author, issuing body

Yeo, Khiok-Khng, author

Zhang, Canhui, 1949- author, photographer

After being injected into tumors, the bacteria self-destruct to release their therapeutic cargo

Almost every agency's funding takes a hit in 2021 budget proposal

Plastic maker will replace naphtha feedstock with tall oil from trees

The industry's reliance on China-based firms for chemistry services is in the spotlight

Lignin breakdown produces phenol and propylene, offering a low-carbon alternative to fossil-fuel-based processes

Deal will resolve dispute over DNA synthesis trade secrets allegedly brought to Twist from Agilent

Newly discovered compounds trap bacteria so they can't grow or divide

A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it

As we age, our skin changes, and so too do the bugs that live there

4 firms have raised more than double their initial expectations

Probiotics, sensors, and MOFs are among technologies that could keep herds healthy as industry turns away from antibiotics

Chemical educator and <i>Compound Interest</i> blogger Andy Brunning explains the CBD craze, how the compound works, and how it's regulated.

Experts praise the approach while remaining skeptical that the highlighted molecules could reach the clinic

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases

Purchase brings the instrumentation giant into the fight against coronavirus

Congress opts for open-ended support for federal and local agencies